Orthofix Medical (OFIX) Cash from Investing Activities (2010 - 2026)

Orthofix Medical has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$10.5 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 56.1% year-over-year to -$10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$38.4 million (down 63.66% YoY) and the FY2025 annual result came in at -$34.6 million, down 25.45% from the prior year.
• Cash from Investing Activities advanced to -$10.5 million in Q1 2026, from -$10.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $17.1 million in Q1 2023 and troughed at -$22.3 million in Q3 2023.
• A 5-year average of -$7.7 million and a median of -$7.5 million in 2022 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 401.46% — and 2025, when it sank 857.8%.
• Tracing OFIX's Cash from Investing Activities over 5 years: stood at -$5.9 million in 2022, then sank by 155.14% to -$15.1 million in 2023, then soared by 92.46% to -$1.1 million in 2024, then plunged by 857.8% to -$10.9 million in 2025, then advanced by 3.27% to -$10.5 million in 2026.
• Business Quant data shows OFIX's Cash from Investing Activities at -$10.5 million in Q1 2026, -$10.9 million in Q4 2025, and -$9.9 million in Q3 2025.